Home
Team
Portfolio
Blog
Contact
Investors
More
Our Recent Posts
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing
RevLocal Acquired by Hibu, an H.I.G. Capital Portfolio Company
Archive
Catalyst OrthoScience Features Two New Products, William Levine, MD Presents The Catalyst CSR™ Total